Resistance training downregulates macrophages infiltration in the kidney of 5/6 nephrectomized rats
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | MORAES, Milton Rocha | |
dc.contributor.author | ROSA, Thiago Santos | |
dc.contributor.author | SOUZA, Michel Kendy | |
dc.contributor.author | NEVES, Rodrigo Vanerson Passos | |
dc.contributor.author | BACURAU, Reury Frank Pereira | |
dc.contributor.author | PASSOS, Clevia Santos | |
dc.contributor.author | CENEDEZE, Marcos Antonio | |
dc.contributor.author | PASSOS, Michelle Tiveron | |
dc.contributor.author | MACHADO, Flavia Gomes | |
dc.contributor.author | PACHECO-SILVA FILHO, Alvaro | |
dc.contributor.author | CAMARA, Niels Olsen Saraiva | |
dc.date.accessioned | 2019-01-17T13:37:02Z | |
dc.date.available | 2019-01-17T13:37:02Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Introduction: Chronic kidney disease (CKD) is considered a significant world health problem with elevated mortality rates. Patients with CKD are restricted to mild physical activity, present chronic inflammatory state and loss of muscle strength. Currently, the influence of resistance exercise (RE) on the progression of renal disease has not being fully elucidated. Purpose: To evaluate the effects of RE on the progression of CKD in a remnant kidney model (5/6Nx) in rats. Methods: Eight-week-old Wistar rats were submitted to 5/6 nephrectomy and were divided into four groups: Sham sedentary (Sham SD); Sham RE (Sham RE); 5/6Nx SD and 5/6Nx RE. The animals were trained for 8 weeks in a vertical climbing ladder for 3 days per week, on non-consecutive days. Results: As expected, 5/6Nx SD group presented a markedly loss of renal function, increased plasma inflammatory cytokines and increased oxidative stress with a reduced activity of nitric oxide. The higher macrophage infiltration and fibrosis confirmed these conditions. RE attenuated systolic blood pressure and renal function decrease and also improved serum lipid parameters in 5/6 Nx animals. It was evident the increase of muscle strength and mass in the trained groups while the sedentary group showed reduced muscle weight and strength compared to Sham SD. Conclusions: RE implemented following 5/6Nx retard the progression of chronic kidney injury while simultaneously allowed the maintenance of skeletal muscle strength. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) | |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) | |
dc.identifier.citation | LIFE SCIENCES, v.213, p.190-197, 2018 | |
dc.identifier.doi | 10.1016/j.lfs.2018.10.037 | |
dc.identifier.eissn | 1879-0631 | |
dc.identifier.issn | 0024-3205 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/30077 | |
dc.language.iso | eng | |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | eng |
dc.relation.ispartof | Life Sciences | |
dc.rights | restrictedAccess | eng |
dc.rights.holder | Copyright PERGAMON-ELSEVIER SCIENCE LTD | eng |
dc.subject | Resistance exercise | eng |
dc.subject | Inflammation | eng |
dc.subject | Muscle strength | eng |
dc.subject | Renal function | eng |
dc.subject | 5/6 nephrectomy | eng |
dc.subject.other | spontaneously hypertensive-rats | eng |
dc.subject.other | stage renal-disease | eng |
dc.subject.other | nitric-oxide | eng |
dc.subject.other | exercise intensity | eng |
dc.subject.other | muscle | eng |
dc.subject.other | individuals | eng |
dc.subject.other | prevention | eng |
dc.subject.other | strength | eng |
dc.subject.other | losartan | eng |
dc.subject.other | receptor | eng |
dc.subject.wos | Medicine, Research & Experimental | eng |
dc.subject.wos | Pharmacology & Pharmacy | eng |
dc.title | Resistance training downregulates macrophages infiltration in the kidney of 5/6 nephrectomized rats | eng |
dc.type | article | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.author.external | MORAES, Milton Rocha:Univ Catolica Brasilia, Grad Program Phys Educ, QS 07,LT1 S-N Sala 110 Bloco G, BR-71966700 Aguas Claras, DF, Brazil; Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil | |
hcfmusp.author.external | ROSA, Thiago Santos:Univ Catolica Brasilia, Grad Program Phys Educ, QS 07,LT1 S-N Sala 110 Bloco G, BR-71966700 Aguas Claras, DF, Brazil; Univ Fed Sao Paulo, Program Translat Med, Dept Med, Sao Paulo, Brazil | |
hcfmusp.author.external | SOUZA, Michel Kendy:Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil | |
hcfmusp.author.external | NEVES, Rodrigo Vanerson Passos:Univ Catolica Brasilia, Grad Program Phys Educ, QS 07,LT1 S-N Sala 110 Bloco G, BR-71966700 Aguas Claras, DF, Brazil; Univ Fed Sao Paulo, Program Translat Med, Dept Med, Sao Paulo, Brazil | |
hcfmusp.author.external | BACURAU, Reury Frank Pereira:Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil | |
hcfmusp.author.external | PASSOS, Clevia Santos:Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil | |
hcfmusp.author.external | CENEDEZE, Marcos Antonio:Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil | |
hcfmusp.author.external | PASSOS, Michelle Tiveron:Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil | |
hcfmusp.author.external | CAMARA, Niels Olsen Saraiva:Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil; Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 6 | |
hcfmusp.contributor.author-fmusphc | FLAVIA GOMES MACHADO | |
hcfmusp.contributor.author-fmusphc | ALVARO PACHECO E SILVA FILHO | |
hcfmusp.description.beginpage | 190 | |
hcfmusp.description.endpage | 197 | |
hcfmusp.description.volume | 213 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 30352243 | |
hcfmusp.origem.scopus | 2-s2.0-85055294449 | |
hcfmusp.origem.wos | WOS:000448413900024 | |
hcfmusp.publisher.city | OXFORD | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Arias SCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056215 | eng |
hcfmusp.relation.reference | Bergamaschi CT, 1997, MED SCI SPORT EXER, V29, P169, DOI 10.1097/00005768-199702000-00001 | eng |
hcfmusp.relation.reference | Bronas UG, 2009, ADV CHRONIC KIDNEY D, V16, P449, DOI 10.1053/j.ackd.2009.07.005 | eng |
hcfmusp.relation.reference | Caso G, 2005, CURR OPIN CLIN NUTR, V8, P73, DOI 10.1097/00075197-200501000-00011 | eng |
hcfmusp.relation.reference | Cheema B, 2010, NEPHROLOGY, V15, P454, DOI 10.1111/j.1440-1797.2009.01261.x | eng |
hcfmusp.relation.reference | Cheema BS, 2014, SPORTS MED, V44, P1125, DOI 10.1007/s40279-014-0176-8 | eng |
hcfmusp.relation.reference | Correa-Costa M, 2012, EUR J PHARMACOL, V689, P233, DOI 10.1016/j.ejphar.2012.05.024 | eng |
hcfmusp.relation.reference | Diment BC, 2015, MED SCI SPORT EXER, V47, P1390, DOI 10.1249/MSS.0000000000000562 | eng |
hcfmusp.relation.reference | Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333 | eng |
hcfmusp.relation.reference | Eghbalzadeh K, 2014, NITRIC OXIDE-BIOL CH, V37, P28, DOI 10.1016/j.niox.2013.12.009 | eng |
hcfmusp.relation.reference | Esfahani PS, 2013, INT J PREVENTIVE MED, V4, pS78 | eng |
hcfmusp.relation.reference | Fujihara CK, 2007, AM J PHYSIOL-RENAL, V292, pF1810, DOI 10.1152/ajprenal.00521.2006 | eng |
hcfmusp.relation.reference | Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041 | eng |
hcfmusp.relation.reference | Goncalves ARR, 2004, AM J PHYSIOL-RENAL, V286, pF945, DOI 10.1152/ajprenal.00238.2003 | eng |
hcfmusp.relation.reference | Grimm Jr R. H., 1997, KIDNEY INT S, V63, pS10 | eng |
hcfmusp.relation.reference | Johansen KL, 2006, J AM SOC NEPHROL, V17, P2307, DOI 10.1681/ASN.2006010034 | eng |
hcfmusp.relation.reference | Johansen KL, 2012, AM J KIDNEY DIS, V59, P126, DOI 10.1053/j.ajkd.2011.10.008 | eng |
hcfmusp.relation.reference | Joles JA, 2013, CLIN EXP PHARMACOL P, V40, P600, DOI 10.1111/1440-1681.12140 | eng |
hcfmusp.relation.reference | Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, pE7, DOI 10.1159/000286344 | eng |
hcfmusp.relation.reference | Lee JongUn, 2016, Chonnam Med J, V52, P81, DOI 10.4068/cmj.2016.52.2.81 | eng |
hcfmusp.relation.reference | Lewis D, 2010, J REN CARE, V36, P27, DOI 10.1111/j.1755-6686.2010.00173.x | eng |
hcfmusp.relation.reference | Luiz RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055363 | eng |
hcfmusp.relation.reference | Mak RH, 2011, J CACHEXIA SARCOPENI, V2, P9, DOI 10.1007/s13539-011-0019-5 | eng |
hcfmusp.relation.reference | Molsted S, 2014, BIOMED RES INT, DOI 10.1155/2014/176190 | eng |
hcfmusp.relation.reference | MOORHEAD JF, 1982, LANCET, V2, P1309 | eng |
hcfmusp.relation.reference | Moraes MR, 2012, J HUM HYPERTENS, V26, P533, DOI 10.1038/jhh.2011.67 | eng |
hcfmusp.relation.reference | Neves R., 2016, ARQ BRAS CARDIOL, V106 | eng |
hcfmusp.relation.reference | Oda H, 1998, NEPHROL DIAL TRANSPL, V13, P45, DOI 10.1093/ndt/13.suppl_1.45 | eng |
hcfmusp.relation.reference | Passos CS, 2012, CAN J PHYSIOL PHARM, V90, P201, DOI [10.1139/Y11-120, 10.1139/y11-120] | eng |
hcfmusp.relation.reference | Passos MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123753 | eng |
hcfmusp.relation.reference | Neves RVP, 2016, ARQ BRAS CARDIOL, V106, P201, DOI 10.5935/abc.20160019 | eng |
hcfmusp.relation.reference | Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007 | eng |
hcfmusp.relation.reference | Peng CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037388 | eng |
hcfmusp.relation.reference | Miyagi MYS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108543 | eng |
hcfmusp.relation.reference | Santana HAP, 2013, AGING CLIN EXP RES, V25, P43, DOI 10.1007/s40520-013-0017-x | eng |
hcfmusp.relation.reference | Sasaki M, 2011, ACTA MED OKAYAMA, V65, P81 | eng |
hcfmusp.relation.reference | Correa CS, 2015, J SPORT MED PHYS FIT, V55, P1037 | eng |
hcfmusp.relation.reference | Souza MK, 2018, LIFE SCI, V206, P93, DOI 10.1016/j.lfs.2018.05.034 | eng |
hcfmusp.relation.reference | Stride M, 2011, BRIT J HOSP MED, V72, P200, DOI 10.12968/hmed.2011.72.4.200 | eng |
hcfmusp.relation.reference | Tremblay AJ, 2004, ATHEROSCLEROSIS, V172, P367, DOI 10.1016/j.atherosclerosis.2003.11.011 | eng |
hcfmusp.relation.reference | Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6 | eng |
hcfmusp.relation.reference | Watson EL, 2015, AM J KIDNEY DIS, V66, P249, DOI 10.1053/j.ajkd.2014.10.019 | eng |
hcfmusp.relation.reference | Wilkinson TJ, 2016, SCAND J MED SCI SPOR, V26, P985, DOI 10.1111/sms.12714 | eng |
hcfmusp.relation.reference | Xie FY, 2017, ENDOCR J, V64, P685, DOI 10.1507/endocrj.EJ17-0012 | eng |
hcfmusp.relation.reference | Y. Ishikawa, 2012, EXP DIABETES RES, V2012 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | deafa5fe-63d9-46d8-890d-c3fea758824b | |
relation.isAuthorOfPublication | c717779e-613a-4cc1-9b3e-8b276ace2bac | |
relation.isAuthorOfPublication.latestForDiscovery | deafa5fe-63d9-46d8-890d-c3fea758824b |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_MORAES_Resistance_training_downregulates_macrophages_infiltration_in_the_kidney_2018.PDF
- Tamanho:
- 1.19 MB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)